Biochemical and molecular modeling studies of the O-methylation of various endogenous and exogenous catechol substrates catalyzed by recombinant human soluble and membrane-bound catechol-O-methyltransferases

被引:71
作者
Bai, Hyoung-Woo
Shim, Joong-Youn
Yu, Jina
Zhu, Bao Ting
机构
[1] Univ Kansas, Sch Med, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS USA
[2] N Carolina Cent Univ, JL Chambers Biomed Biotechnol Res Inst, Durham, NC 27707 USA
关键词
D O I
10.1021/tx700174w
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Catechol-O-methyltransferase (COMT, EC 2.1.1.6) catalyzes the O-methylation of a wide array of catechol-containing substrates using s-adenoSyl-L-methionine as the methyl donor. In the present study, we have cloned and expressed the human soluble and membrane-bound COMTs (S-COMT and MB-COMT, respectively) in Escherichia coli and have studied their biochemical characteristics for the O-methylation of representative classes of endogenous catechol substrates (catecholamines and catechol estrogens) as well as exogenous catechol substrates (bioflavonoids and tea catechins). Enzyme kinetic analyses showed that these two recombinant human COMTs are functionally active, with catalytic and. kinetic properties nearly identical to those of crude or purified enzymes prepared from human tissues or cells. Kinetic parameters for the O-methylation of various substrates were characterized. In addition, computational modeling studies were conducted to better understand the molecular mechanisms for the different catalytic behaviors of human S- and MB-COMTs with respect to s-adenosyl-L-methionine, various substrates, and also the regioselectivity for the formation of mono-methyl ether products. Our modeling data showed that the binding energy values (Delta G) calculated for most substrates agreed well with the measured kinetic parameters. Also, our modeling data precisely predicted the regioselectivity for the O-methylation of these substrates at different hydroxyl groups, the predicted values matched nearly perfectly with the experimental data.
引用
收藏
页码:1409 / 1425
页数:17
相关论文
共 63 条
[1]  
Åqvist J, 2001, COMB CHEM HIGH T SCR, V4, P613
[2]  
AXELROD J, 1958, J BIOL CHEM, V233, P702
[3]  
AXELROD J, 1966, PHARMACOL REV, V18, P95
[4]   Excretion of 2- and 3-monomethyl ethers of 2-hydroxyestrogens in healthy male volunteers [J].
Banger, M ;
Hiemke, C ;
Haupt, M ;
Knuppen, R .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1996, 135 (02) :193-197
[5]   HUMAN CATECHOL-O-METHYLTRANSFERASE - CLONING AND EXPRESSION OF THE MEMBRANE-ASSOCIATED FORM [J].
BERTOCCI, B ;
MIGGIANO, V ;
DAPRADA, M ;
DEMBIC, Z ;
LAHM, HW ;
MALHERBE, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (04) :1416-1420
[6]   Expression and characterization of rat soluble catechol-O-methyltransferase fusion protein [J].
Bonifácio, MJ ;
Vieira-Coelho, MA ;
Soares-da-Silva, P .
PROTEIN EXPRESSION AND PURIFICATION, 2001, 23 (01) :106-112
[7]  
BRYANLLUKA LJ, 1995, N-S ARCH PHARMACOL, V351, P408
[8]   A novel shape complementarity scoring function for protein-protein docking [J].
Chen, R ;
Weng, ZP .
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2003, 51 (03) :397-408
[9]   Catechol-O-methyltransferase:: variation in enzyme activity and inhibition by entacapone and tolcapone [J].
De Santi, C ;
Giulianotti, PC ;
Pietrabissa, A ;
Mosca, F ;
Pacifici, GM .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 54 (03) :215-219
[10]  
Ding Yu-Shin, 1996, Life Sciences, V58, P195